ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹1,521 Cr | ₹1,411 Cr | ₹1,260 Cr | ₹1,149 Cr | ₹971 Cr |
What is the latest Total Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹1,521 Cr |
Mar2023 | ₹1,411 Cr |
Mar2022 | ₹1,260 Cr |
Mar2021 | ₹1,149 Cr |
Mar2020 | ₹971 Cr |
How is Total Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,521 Cr | 7.85 | |
Mar2023 | ₹1,411 Cr | 11.93 | |
Mar2022 | ₹1,260 Cr | 9.65 | |
Mar2021 | ₹1,149 Cr | 18.34 | |
Mar2020 | ₹971 Cr | - |
Compare Total Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,091.8 Cr | -1.3% | -16.8% | -24.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | -1.3% |
-16.8% |
-24.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses